Treatment Studies Using Depot Naltrexone (4/6) Columbia Protocol Treatment Site
使用长效纳曲酮 (4/6) 哥伦比亚方案治疗站点的治疗研究
基本信息
- 批准号:8037045
- 负责人:
- 金额:$ 37.85万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2008
- 资助国家:美国
- 起止时间:2008-09-15 至 2014-02-28
- 项目状态:已结题
- 来源:
- 关键词:Active SitesAddressAgonistAlcoholismAreaAuthorization documentationBaltimoreBuprenorphineChronicClinical TreatmentClinical TrialsCoercionCommunitiesControl GroupsControlled StudyCost-Benefit AnalysisCounselingCrimeCriminal JusticeDataDepot PreparationDoctor of MedicineDoctor of PhilosophyDrug FormulationsDrug Metabolic DetoxicationDrug usageEconomicsEffectivenessEmploymentEnrollmentEthical IssuesEthicsEvaluationFDA approvedFoundationsFriendsFundingGoalsHIVHabitsHairHealthHealth ServicesHepatitis CHepatitis C TransmissionHeroinHospitalsImprisonmentIncentivesIndividualInfectionInformed ConsentInjectableInjection of therapeutic agentInterventionIntravenousLegalMaintenanceMeasuresMedicalMethadoneMonitorMorbidity - disease rateMotivationNaloxoneNaltrexoneNeedle SharingNew YorkOnline SystemsOpiate AddictionOpiatesOpioidOpioid ReceptorOralOutcomeOutcome MeasureParticipantPatient Self-ReportPatientsPennsylvaniaPerformancePersonsPharmaceutical PreparationsPhiladelphiaPlacebosPopulationPrisonsProceduresProductivityProtocols documentationPublic HealthRandomizedRecording of previous eventsRecordsRecruitment ActivityRelapseRelative (related person)ReportingResearchResearch InstituteRhode IslandRiskRisk BehaviorsRoleSample SizeSamplingServicesSiteSystemTechnologyTestingTreatment CostTreatment ProtocolsTreatment outcomeUnited StatesUniversitiesUnsafe SexUrineVirginiaVisitaddictionalcohol and other drugalcoholism therapycaregivingcomparison groupcostdata managementdesigndisorder later incidence preventiondrug abusereconomic valueeffective therapyeffectiveness trialefficacy trialfollow-uphigh riskimprovedinnovationmeetingsmortalityparoleparoleepilot trialplacebo controlled studypreventprobationerprogramspsychosocialrestraintsocialsymposiumtreatment as usualtreatment effecttreatment programtreatment sitevolunteervoucher
项目摘要
DESCRIPTION (provided by applicant): Opioid addiction has remained widespread throughout the United States since the 1960s and a large proportion of users are involved in crimes to support their habits. After release from incarceration, relapse to opioid addiction is very common and this leads to more crimes and re-incarceration. Treatment advances in the area of medications have not reached this population. Effective medications such as methadone and buprenorphine are not well accepted by prosecutors and judges. Permission to conduct research on the most effective treatment approaches is very difficult to obtain for patients under legal restraint because informed consent is problematic. Naltrexone, an opiate receptor antagonist, has demonstrated pharmacological efficacy in preventing relapse to opioid addiction and it has been reported to be clinically effective in parolee populations although it is rarely used. Recently a depot formulation with a one month duration has received FDA approval for the treatment of alcoholism. The purpose of this study is to determine whether a monthly injection of naltrexone is practical and useful in the prevention of relapse and when compared to treatment as usual. We will also monitor HIV risk behaviors to determine whether the intervention reduces risk of HIV and hepatitis C infections. This collaborative project will take place in six treatment sites where there is a large population of parolees with a history of opiate addiction. In order to prevent even a subtle form of coercion, referrals from parole officers will not be accepted. After determining that all volunteers are opiate free by urine test and not currently opiate dependent using a naloxone test, they will be randomized to depot naltrexone or Treatment as Usual (TAU). Participants in both groups will be given identical follow up monthly for six months with measures of opiate use by self-report, urine test and hair analysis. An additional random urine test will take place each month between monthly visits. Both groups will be re-evaluated six and 12 months later. The University of Pennsylvania will be the coordinating site and each site will have a randomization goal of 20 new patients per year over 3.5 to 4 years to accrue a total of 360 to 400 participants. Treatment outcome will be measured by urine tests, hair analysis, self-report and continuation in treatment. Both naltrexone and comparison groups will receive equivalent voucher incentives to remain in the program. A benefit-cost analysis will be conducted to compare the costs of the treatment with the quantifiable benefits in terms of reduced crime, re-incarceration and medical services and increased employment. PUBLIC HEALTH RELEVANCE: This project will test the benefits of a new treatment using a depot medication for preventing relapse to opioid addiction. If successful, it will influence the care given to probationers and parolees and likely relieve some of the overcrowding of our prisons. The data from this study can also be used by the FDA to evaluate the benefits of this treatment that could improve the lives of patients suffering from opioid addiction.
描述(由申请人提供):自20世纪60年代以来,阿片类药物成瘾在美国仍然很普遍,很大一部分用户参与犯罪以支持他们的习惯。从监禁中释放后,阿片类药物成瘾复发是非常常见的,这导致更多的犯罪和重新监禁。药物治疗领域的进展尚未惠及这一人群。有效的药物,如美沙酮和丁丙诺啡,并不为检察官和法官所接受。在法律的限制下,患者很难获得对最有效治疗方法进行研究的许可,因为知情同意是有问题的。纳洛酮是一种阿片受体拮抗剂,已证明在预防阿片类药物成瘾复发方面具有药理学疗效,据报道,纳洛酮在假释人群中具有临床有效性,但很少使用。最近,具有一个月持续时间的储库制剂已获得FDA批准用于治疗酒精中毒。本研究的目的是确定每月注射纳洛酮是否在预防复发方面是实用和有用的,并且与常规治疗相比。我们还将监测艾滋病毒风险行为,以确定干预措施是否降低了艾滋病毒和丙型肝炎感染的风险。这一合作项目将在六个治疗地点进行,那里有大量有阿片成瘾史的假释犯。为了防止即使是微妙的胁迫形式,假释官的转介将不被接受。在通过尿液检测确定所有志愿者均无阿片类药物,并且使用纳洛酮检测确定目前无阿片类药物依赖性后,将其随机分配至长效纳洛酮组或按剂量治疗(TAU)组。两组受试者将每月接受相同的随访,持续6个月,通过自我报告、尿检和毛发分析测量阿片类药物的使用情况。在每月访视之间,每月将进行额外的随机尿液检查。两组将在6个月和12个月后重新评估。宾夕法尼亚大学将作为协调研究中心,每家研究中心的随机化目标是在3.5至4年内每年20例新患者,以招募总计360至400例受试者。治疗结果将通过尿检、毛发分析、自我报告和治疗持续进行测量。纳洛酮和对照组都将获得同等的代金券奖励,以留在该计划中。将进行效益-成本分析,以比较治疗费用与减少犯罪、重新监禁和医疗服务以及增加就业等方面的可量化效益。公共卫生相关性:该项目将测试一种使用长效药物预防阿片类药物成瘾复发的新治疗方法的益处。如果成功的话,它将影响对缓刑犯和假释犯的照顾,并可能缓解我们监狱的过度拥挤。这项研究的数据也可以被FDA用来评估这种治疗的益处,这种治疗可以改善阿片类药物成瘾患者的生活。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Edward V. Nunes其他文献
Dissociative identity disorder and substance abuse: the forgotten relationship.
分离性身份障碍和药物滥用:被遗忘的关系。
- DOI:
- 发表时间:
1999 - 期刊:
- 影响因子:2.8
- 作者:
David McDowell;Frances R. Levin;Edward V. Nunes - 通讯作者:
Edward V. Nunes
Anger and depressive states among treatment-seeking drug abusers: testing the psychopharmacological specificity hypothesis.
寻求治疗的药物滥用者的愤怒和抑郁状态:检验精神药理学特异性假设。
- DOI:
- 发表时间:
2001 - 期刊:
- 影响因子:3.7
- 作者:
E. Aharonovich;Hueco T. Nguyen;Edward V. Nunes - 通讯作者:
Edward V. Nunes
The neuropsychological assessment battery (S-NAB) in cocaine-dependent patients
- DOI:
10.1016/j.drugalcdep.2014.02.030 - 发表时间:
2014-07-01 - 期刊:
- 影响因子:
- 作者:
Efrat Aharonovich;Edward V. Nunes;D. Cannizzaro;M. Stohl;Deborah S. Hasin - 通讯作者:
Deborah S. Hasin
New Directions in Medication-Facilitated Behavioral Treatment for Substance Use Disorders
- DOI:
10.1007/s11920-016-0703-4 - 发表时间:
2016-05-25 - 期刊:
- 影响因子:6.700
- 作者:
Elias Dakwar;Edward V. Nunes - 通讯作者:
Edward V. Nunes
Rapid Initiation of Injection Naltrexone for Opioid Use Disorder
快速开始注射纳曲酮治疗阿片类药物使用障碍
- DOI:
10.1001/jamanetworkopen.2024.9744 - 发表时间:
2024 - 期刊:
- 影响因子:13.8
- 作者:
Matisyahu Shulman;Miranda G Greiner;Hiwot M. Tafessu;Onumara Opara;Kaitlyn Ohrtman;Kenzie Potter;Kathryn Hefner;Eve Jelstrom;Richard N Rosenthal;K. Wenzel;Marc Fishman;John Rotrosen;Udi E. Ghitza;Edward V. Nunes;Adam Bisaga - 通讯作者:
Adam Bisaga
Edward V. Nunes的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Edward V. Nunes', 18)}}的其他基金
NIDA Clinical Trials Network: New York Node
NIDA 临床试验网络:纽约节点
- 批准号:
10647100 - 财政年份:2022
- 资助金额:
$ 37.85万 - 项目类别:
NIDA Clinical Trials Network: Greater New York Node
NIDA 临床试验网络:大纽约节点
- 批准号:
9814170 - 财政年份:2018
- 资助金额:
$ 37.85万 - 项目类别:
Treatment Studies Using Depot Naltrexone (4/6) Columbia Protocol Treatment Site
使用长效纳曲酮 (4/6) 哥伦比亚方案治疗站点的治疗研究
- 批准号:
7514307 - 财政年份:2008
- 资助金额:
$ 37.85万 - 项目类别:
Treatment Studies Using Depot Naltrexone (4/6) Columbia Protocol Treatment Site
使用长效纳曲酮 (4/6) 哥伦比亚方案治疗站点的治疗研究
- 批准号:
8235961 - 财政年份:2008
- 资助金额:
$ 37.85万 - 项目类别:
Treatment Studies Using Depot Naltrexone (4/6) Columbia Protocol Treatment Site
使用长效纳曲酮 (4/6) 哥伦比亚方案治疗站点的治疗研究
- 批准号:
8437265 - 财政年份:2008
- 资助金额:
$ 37.85万 - 项目类别:
Treatment Studies Using Depot Naltrexone (4/6) Columbia Protocol Treatment Site
使用长效纳曲酮 (4/6) 哥伦比亚方案治疗站点的治疗研究
- 批准号:
7686108 - 财政年份:2008
- 资助金额:
$ 37.85万 - 项目类别:
Drug Abuse Treatment Development and Research Mentoring
药物滥用治疗开发和研究指导
- 批准号:
8069902 - 财政年份:2007
- 资助金额:
$ 37.85万 - 项目类别:
Drug Abuse Treatment Development and Research Mentoring
药物滥用治疗开发和研究指导
- 批准号:
7180794 - 财政年份:2007
- 资助金额:
$ 37.85万 - 项目类别:
Drug Abuse Treatment Development and Research Mentoring
药物滥用治疗开发和研究指导
- 批准号:
8653944 - 财政年份:2007
- 资助金额:
$ 37.85万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 37.85万 - 项目类别:
Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 37.85万 - 项目类别:
Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 37.85万 - 项目类别:
Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 37.85万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 37.85万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 37.85万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 37.85万 - 项目类别:
EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 37.85万 - 项目类别:
Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 37.85万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 37.85万 - 项目类别:
Research Grant